Kaya Limited
Key Quantitative Figures
The company has received approval for the listing, issue, and allotment of up to 4,00,000 (Four Lakh) equity shares with a face value of ₹10 each.
Dates of Action
- Approval received from both exchanges on October 14, 2026
- BSE reference: DCS/ESOP/IP/RD/277/2026-27 dated October 14, 2026
- NSE reference: NSE/LIST/57642 dated October 14, 2026
Parties Involved
- Issuing Company: Kaya Limited
- Regulatory Authorities: BSE Limited, National Stock Exchange of India Limited
- Beneficiaries: Permanent employees of Kaya Limited and employees of its subsidiary/(ies)
Conditions for Approval
Both exchanges have specified identical conditions that must be fulfilled:
1. Notification to exchanges as per Regulation 10(c) format after shares are allotted and credited to beneficiaries' accounts or share certificates dispatched
2. Payment of prescribed fees
3. Receipt of statutory approvals from SEBI, RBI, MCA, and other authorities
4. Compliance with all guidelines/regulations/directions of exchanges and statutory authorities
5. Compliance with SEBI (LODR) Regulations, 2015 conditions as on date of listing
6. Compliance with Companies Act, 1956/2013 and other applicable laws
7. Submission of documents as per checklists available on BSE and NSE websites
Additional Requirements from NSE
The NSE specifically requires submission of:
- Certified true copy of statement under Regulation 10(c)
- NSDL/CDSL credit confirmation or physical certificate dispatch confirmation
- Certified true copy of Board resolution of allotment
- List of allottees with names and number of shares allotted
- Details of employees granted options/shares in excess of 1% of share capital
- Confirmation and details if any Directors have been issued shares under ESOP
Reservations and Limitations
The exchanges reserve the right to withdraw in-principle approval if:
- Submitted information is found incomplete, incorrect, misleading, or false
- There is contravention of Rules, Bye-laws, and Regulations of the Exchange
- There is violation of Listing Agreement or guidelines/regulations issued by statutory authorities
The approval does not constitute approval under any other Act/Regulation/rule/bye laws, and the company must separately obtain approvals from other departments if required.
Financial Impact
Financial impact not quantified in the disclosure. The approval covers potential issuance of up to 4,00,000 equity shares, but actual issuance depends on exercise of options by employees.